Prognostic Value of Neutrophil-to-Lymphocyte Ratio Following Chemoradiation Therapy for Stage III Non–small Cell Lung Cancer

Authors :: Nitin Ohri
Chandan Guha
S.C. Desai
K. O'Grady
Shalom Kalnicki
Madhur Garg
W.R. Bodner
Source :: International Journal of Radiation Oncology*Biology*Physics. 99:E451-E452
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
business.industry
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
Neutrophil to lymphocyte ratio
business
Value (mathematics)
Stage III Non-Small Cell Lung Cancer

Full Text Access

Tools